[Evaluation of the effectiveness of immunomodulating therapy in children with chronic gastroduodenitis].

The article assesses the effectiveness of administering immunomodulating drug cycloferon in patients aged 10 to 16 years with chronic gastroduodenitis. It is established that the use of cycloferon in children with virus-associated chronic gastroduodenitis leads to a significant increase in T- and B-lymphocyte populations in mucous membranes of the stomach and duodenum, and contributes to the elimination of viruses. This results in reduced severity and activity of inflammation in the mucous membranes and decreases clinical manifestations of the disease.

[Nephropathic variant of AL-amyloidosis].

One case of a nephropathic variant of primary amyloidosis is described. Genetic or familial genesis of the disease is considered on the basis of anamnesis.